Unituxin Interactions
There are 294 drugs known to interact with Unituxin (dinutuximab), along with 6 disease interactions. Of the total drug interactions, 70 are major, and 224 are moderate.
- View all 294 medications that may interact with Unituxin
- View Unituxin disease interactions (6)
Most frequently checked interactions
View interaction reports for Unituxin (dinutuximab) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Afinitor Disperz (everolimus)
- amlodipine
- ampicillin / sulbactam
- Arava (leflunomide)
- Arcapta (indacaterol)
- Austedo (deutetrabenazine)
- Avelox I.V. (moxifloxacin)
- axicabtagene ciloleucel
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Barhemsys (amisulpride)
- belantamab mafodotin
- Belsomra (suvorexant)
- Benemid (probenecid)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bosulif (bosutinib)
- Buphenyl (sodium phenylbutyrate)
- BuSpar (buspirone)
- Cardizem LA (diltiazem)
- Cathflo Activase (alteplase)
- Cayston (aztreonam)
- Celebrex (celecoxib)
- Cerezyme (imiglucerase)
- chloramphenicol ophthalmic
- clonidine
- Copaxone (glatiramer)
- Corlanor (ivabradine)
Unituxin disease interactions
There are 6 disease interactions with Unituxin (dinutuximab) which include:
- electrolytes abnormalities
- hemolytic uremic syndrome
- hypotension
- myelosuppression
- neurotoxicity
- posterior leukoencephalopathy syndrome
Report options
QR code containing a link to this page
More about Unituxin (dinutuximab)
- Unituxin consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.